(Q70032693)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Urinary norepinephrine excretion in panic and phobic disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

F Dajas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

A Nin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

L Barbeito

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

75-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

High urinary norepinephrine excretion in major depressive disorders: effects of a new type of MAO inhibitor (Moclobemide, RO 11-1163)

8 October 2019

cites work

1 reference

12 December 2020

Resting urinary catecholamine excretion in schizophrenics: methodology and interpretation of results

1 reference

12 December 2020

Differential diagnosis and treatment of panic attacks and phobic states

1 reference

12 December 2020

Current concepts in psychiatry. Panic attacks and phobias

1 reference

12 December 2020

The locus coeruleus: actions of psychoactive drugs.

1 reference

12 December 2020

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

1 reference

12 December 2020

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis

1 reference

12 December 2020

Resting Plasma Catecholamine Concentrations in Patients With Depression and Anxiety

1 reference

12 December 2020

A Rating Instrument For Anxiety Disorders

1 reference

12 December 2020

The relationship of plasma free MHPG to anxiety and psycho-physical pain in normal volunteers.

1 reference

12 December 2020

Behavior and circulating catecholamines

1 reference

12 December 2020

Plasma noradrenaline and clinical psychopathology in schizophrenia. A correlation analysis.

1 reference

12 December 2020

Genetic factors in anxiety disorders.

1 reference

12 December 2020

Neural and extraneural catecholamine production by rat kidneys

1 reference

12 December 2020

Adrenergic function in patients with panic anxiety

1 reference

12 December 2020

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

1 reference

12 December 2020

Lactate provocation of panic attacks. I. Clinical and behavioral findings.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01249613

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3958707%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference